Chronic Lymphocytic Leukemia Treatment (PDQ®): Treatment - Patient Information [NCI] - Treatment Options for Refractory Chronic Lymphocytic Leukemia

Treatment of refractory chronic lymphocytic leukemia may include the following:

  • Repeat treatment with monoclonal antibody therapy and combination chemotherapy.
  • A clinical trial of chemotherapy with stem cell transplant.
  • A clinical trial of a new treatment.

Check the list of NCI-supported cancer clinical trials that are now accepting patients with refractory chronic lymphocytic leukemia. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.

WebMD Public Information from the National Cancer Institute
This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.Some material in CancerNet™ is from copyrighted publications of the respective copyright claimants. Users of CancerNet™ are referred to the publication data appearing in the bibliographic citations, as well as to the copyright notices appearing in the original publication, all of which are hereby incorporated by reference.